Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy
- 1 June 2004
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 93 (11) , 32-48
- https://doi.org/10.1016/j.amjcard.2004.02.004
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Epidemic Obesity and the Metabolic SyndromeCirculation, 2003
- Diagnosis, prevention, and intervention for the metabolic syndromeThe American Journal of Cardiology, 2003
- Task force #1—identification of coronary heart disease risk: is there a detection gap?Journal of the American College of Cardiology, 2003
- Age and Sex Distribution of Subclinical Aortic AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Prevalence of Clinical and Isolated Subclinical Cardiovascular Disease in Older Adults With Glucose DisordersDiabetes Care, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Diabetes MellitusArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Traditional Risk Factors and Subclinical Disease Measures as Predictors of First Myocardial Infarction in Older AdultsArchives of internal medicine (1960), 1999
- Prevalence of Subclinical Atherosclerosis and Cardiovascular Disease and Association with Risk Factors in the Cardiovascular Health StudyAmerican Journal of Epidemiology, 1994
- Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging.Circulation, 1986